The commercial success of large-volume biologics hinges on overcoming the major challenges they pose: They are hard for patients to take, hard to make, and costly. But they become a marketer’s dream when combined with Enable Injections’ advanced patient-focused large-volume wearable injector technology. It’s why combination product partnerships are rapidly proliferating.
